Ask five people in your company what you do and you'll get five answers. That's the brand problem. The colours are fine.
Book a Strategy CallSay "echo" to a cardiologist and they picture an image on a screen.
If what you actually sell is measurement, you've lost them in the first word. Not because the product's wrong. Because they filed you on the wrong shelf before you reached slide two, and everything you say afterwards gets read from that shelf.
That's a branding problem. It has nothing to do with your logo.
Founders usually describe this to us in visual terms. The site looks dated. The deck and the website disagree. The logo was done by a co-founder's friend in 2019.
So we ask five people in the company what the company does. Separately. And we get five different answers.
Not five wrong ones, which is what makes this so hard to catch. Five reasonable descriptions of the same product, aimed at different problems, in different language.
A new visual identity then goes on top of that. Six months later nothing has moved, because the broken thing was never visual.
"You don't have a demand problem. You have a definition problem."
Omar Khateeb, CEO, MarketCraft
A hospital committee has to answer three questions before anyone can sign. What is this? What does it replace? And what happens if we do nothing?
Question one is the brand question. If nobody has handed them a clean answer, they never reach questions two and three.
They can't compare you to anything. They can't price the risk. And they can't defend the decision to a colleague if it goes badly in eighteen months.
So they defer. Deferring is free.
That's what most of your stalled deals are. Not lost, and not objected to. Filed under later by people who couldn't place you.
Your reps live inside this. They spend the first twenty minutes of every meeting explaining what you are, then sell in whatever time is left. And every campaign you fund pays to explain the same thing from scratch, so the spend never compounds.
In consumer, a brand is how people feel about you. In medtech, a brand is where people file you.
Your buyer isn't choosing between you and a feeling. They're a value analysis committee with a shortlist, a budget line, and a decision they'll have to defend. What they need from your brand is a slot to put you in, and a reason that slot should have money in it.
So the work is definition, and identity comes after.
The name of that slot is what marketers call a category. Most medtech companies never pick theirs. It gets picked for them, badly, by whoever describes them first, and that's usually a competitor with a simpler story and a bigger budget.
The shelf you belong on. The narrowest space you can own completely, rather than the huge addressable market that reads well in a deck and wins you nothing. We name the exact clinical scenario where you're the obvious answer, and you expand out from there.
The problem, defined twice. Once clinically, so your surgeon advocate gets excited. Once economically, so the committee has a number to work with. Most medtech messaging only ever builds the first half, which is why all that enthusiasm keeps failing to convert.
The story of why you exist. What the world looks like with your category in it, and what it looks like without. That's the piece that makes a company feel inevitable instead of optional.
One page that settles every argument. Every claim you make, mapped to the proof behind it. Four columns: the category, the problem defined both ways, what makes you different, and the evidence for each claim. When your deck, your website and your best rep disagree about what you do, this is the document that decides it.
Rules that outlive your next marketing hire. The internal charter that governs future market decisions, so none of this quietly unravels when the person who commissioned it leaves.
You own all five permanently, including if you never work with us again.
Founders and commercial leaders who recognise at least two of these.
Pre-clearance is the cheapest moment to do this. Post-clearance is the most common.
We're the wrong call if what you need is a visual identity system, a logo, or packaging design. Those are real jobs and there are good firms who do them. We'll point you at one rather than take the work.
Six to eight weeks, kickoff to a finished set of documents.
We start with a kickoff, then a structured working session with your team. We do the drafting. You review and approve at each milestone rather than all at once at the end, so nothing arrives as a surprise.
Most clients then move into commercial traction, where the category gets taught to the market. If you'd rather take the documents in-house and run them yourself, that's a legitimate outcome and we build them to survive it.
MarketCraft is a medtech brand and market engineering agency, founded by Omar Khateeb. Omar sold surgical robots into hospitals before he built the firm, so he knows what happens in the room after your rep leaves.
He hosts State of MedTech, a podcast past 400 episodes with the founders, investors and operators in this industry.
That matters more here than on most engagements. Naming a medtech category means knowing how hospitals buy, what a value analysis committee asks, and where a claim falls apart under a clinician. A generalist brand agency is guessing at all three.
The method isn't ours alone. MarketCraft is acknowledged in Market Engineering by Bruce Cleveland, published June 2026. Cleveland ran product and marketing at Apple and Oracle, then became a founding partner at Wildcat Venture Partners. He built the framework after watching funded companies with working products stall in the gap between shipping and traction.
"MarketCraft joined the board of investors meeting, they were very impressed by MarketCraft's results."
Lloyd Mencinger, CEO, Aqua Medical
No. We do the strategy the visual work should be built on, and we'll happily brief your designer or recommend one. Getting these in the wrong order is why so many rebrands change nothing.
Usually not. Most rebrands redo how you look and leave what you are untouched. If your team still gives five different answers, the rebrand didn't reach the layer that was broken.
Yes, and it's normally the best time. The market takes longer to form than the product does, so you want the head start.
The founder or CEO, whoever owns commercial, and your strongest clinical voice. Three or four people for half a day, and you won't need them again until the review.
Then we haven't finished. It has to be one your team will defend for years, so we build it with you rather than present it to you.
If you can't describe your category in one sentence, that's the whole conversation. It takes about ten minutes to find out.
Thirty minutes with a founder who has sold medical devices himself. No deck.
P.S. The fastest way to test this yourself costs nothing. Email the same question to five people on your team this afternoon, separately, and compare what comes back. Founders who do that usually book the call the same day.